World News

ESMO welcomes the adoption of European Parliament Report on Europe’s Beating...

Ogkologos - 30 Σεπτεμβρίου, 2026

European Parliament Report on Europe’s Beating Cancer Plan Strengthens Commitment to...

Ogkologos - 30 Σεπτεμβρίου, 2026

FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in combination with nivolumab...

Ogkologos - 30 Σεπτεμβρίου, 2026

Beginning Surveillance Colonoscopy After 5 Years from Removal of High-Risk Adenomas...

Ogkologos - 29 Σεπτεμβρίου, 2026

Tambotatug Pelitecan Leads to Better Clinical Outcomes than Topotecan Among Patients...

Ogkologos - 28 Σεπτεμβρίου, 2026

ESMO Welcomes European Parliament Calls to Strengthen and Protect Europe’s Cancer...

Ogkologos - 24 Σεπτεμβρίου, 2026

No improvement in OS, but more grade 3 or higher AEs...

Ogkologos - 24 Σεπτεμβρίου, 2026

FDA approves lutetium Lu 177 vipivotide tetraxetan with ARPI therapy for...

Ogkologos - 23 Σεπτεμβρίου, 2026

ESMO Calls on the European Commission to Fund Cancer Research and...

Ogkologos - 23 Σεπτεμβρίου, 2026

Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over...

Ogkologos - 22 Σεπτεμβρίου, 2026

1...456...432 Σελίδα 5 από 432

MOST POPULAR

Program Connects Adolescents and Young Adults to Quality Cancer Care

24 Οκτωβρίου, 2024

Olaparib Plus Bevacizumab Provides Clinically Meaningful OS Improvement for Newly Diagnosed...

31 Μαΐου, 2023

High Jumper Training for Her Fifth Olympics Uses Personal Breast Cancer...

9 Δεκεμβρίου, 2020

Diverse Genomic and Histologic Mechanisms of Resistance to KRASG12C Inhibition Described

25 Ιουνίου, 2021

Φόρτωση περισσοτέρων

ESMO welcomes the adoption of European Parliament Report on Europe’s Beating...

European Parliament Report on Europe’s Beating Cancer Plan Strengthens Commitment to...

FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in combination with nivolumab...

Beginning Surveillance Colonoscopy After 5 Years from Removal of High-Risk Adenomas...

Tambotatug Pelitecan Leads to Better Clinical Outcomes than Topotecan Among Patients...

ESMO Welcomes European Parliament Calls to Strengthen and Protect Europe’s Cancer...

No improvement in OS, but more grade 3 or higher AEs...

FDA approves lutetium Lu 177 vipivotide tetraxetan with ARPI therapy for...

ESMO Calls on the European Commission to Fund Cancer Research and...

Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over...

MOST POPULAR

Program Connects Adolescents and Young Adults to Quality Cancer Care

Olaparib Plus Bevacizumab Provides Clinically Meaningful OS Improvement for Newly Diagnosed...

High Jumper Training for Her Fifth Olympics Uses Personal Breast Cancer...

Diverse Genomic and Histologic Mechanisms of Resistance to KRASG12C Inhibition Described

HOT NEWS

How to Talk About Cancer With Someone Who Has It

ASCO20 Virtual Research Round Up Podcast: Breast Cancer, Sarcoma, and Supportive...

2022 ASCO Annual Meeting Research Round Up: New Research in Head...

Nivolumab and Ipilimumab Effective against Melanoma That Has Spread to the...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ